Authors:
Dardari, R
Hinderer, W
Lang, D
Benider, A
EL Gueddari, B
Joab, I
Benslimane, A
Khyatti, M
Citation: R. Dardari et al., Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: Complementary test of ZEBRA protein and early antigens p54 and p138, J CLIN MICR, 39(9), 2001, pp. 3164-3170
Authors:
Murono, S
Inoue, H
Tanabe, T
Joab, I
Yoshizaki, T
Furukawa, M
Pagano, JS
Citation: S. Murono et al., Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells, P NAS US, 98(12), 2001, pp. 6905-6910
Citation: D. Martel-renoir et al., Dimerization of the Epstein-Barr virus ZEBRA protein in the yeast two-hybrid system. Comparison of a ZEBRA variant with the B95-8 form, BIOCHIMIE, 82(2), 2000, pp. 139-145
Authors:
Fahmi, H
Cochet, C
Hmama, Z
Opolon, P
Joab, I
Citation: H. Fahmi et al., Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway, J VIROLOGY, 74(13), 2000, pp. 5810-5818
Authors:
Dardari, R
Khyatti, M
Benider, A
Jouhadi, H
Kahlain, A
Cochet, C
Mansouri, A
El Gueddari, B
Benslimane, A
Joab, I
Citation: R. Dardari et al., Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma, INT J CANC, 86(1), 2000, pp. 71-75